Post-surgical patient triage is a key part of care. It includes checking how patients recover, finding any problems, and setting up follow-up appointments. Usually, clinicians and nurses spend a lot of time making phone calls, entering data, coordinating appointments, and doing clinical assessments. This adds to their workload and can cause longer wait times and delays for patients.
AI clinical assistants use conversation technology and machine learning to do first triage checks. They can make follow-up calls by themselves, gather symptom information, find patients who need more attention, and clear those with simple recoveries. This lowers human workload and lets healthcare workers focus on patients who need more help.
A study in the UK tested an AI assistant called Dora R1 for follow-up after cataract surgery. It made 96.5% of follow-up calls on its own and correctly identified 94% of patients who needed extra care. Even though it was done in the UK, similar ideas can be used in the U.S., especially where there are many patients and fewer staff.
One reason U.S. medical practices use AI clinical assistants is to save money. Studies show AI can cut staff costs for routine post-surgery follow-ups by a lot.
For example, the Dora R1 AI assistant saved about £35.18 (near $44) per patient by automating calls and triage tasks, while keeping safety and accuracy. This saves nursing and admin time.
Other reports say AI can cut admin costs in healthcare by up to 25%. Tasks like scheduling, updating patient records, billing, and checking insurance are faster and need less labor. For administrators and owners, this means better budget control and possibly more money for patient care or new services.
AI also helps reduce no-show rates, which cost doctors around $200 per missed appointment. Automated reminders and confirmations from AI help keep revenue steady and make better use of doctors’ time.
AI automation is becoming important in making healthcare work better and faster. In U.S. medical offices, this helps with efficiency, accuracy, and focusing on patients.
Important AI automations include:
Bringing in this automation needs careful fitting with current hospital systems, electronic records, and communication tools. Training staff and customizing AI are needed so it works well with clinical processes.
Safety and accuracy stay very important when using AI for post-surgery follow-ups. Missing a complication can cause serious problems.
The Dora R1 study showed AI could find problems with 94% sensitivity and 86% specificity. This means AI can help make good clinical decisions. Still, doctors review AI outcomes to avoid wrong discharges or missed treatments.
Patients feel differently about AI. For simple follow-ups, most accept AI calls. But for hard or emotional cases, some want a human voice. Medical practices may need to balance AI use with personal contact to keep patients comfortable.
Following U.S. rules is key too. AI must protect patient privacy under HIPAA. It also needs to meet FDA and state rules to keep clinical trust and protect rights.
Companies like Simbo AI make phone automation and answering systems for healthcare. Their AI works with existing practice systems to handle routine calls, improve triage workflows, and reduce staff workload.
Simbo AI offers benefits like:
Administrators and IT managers who adopt AI like Simbo AI can meet goals for cost saving, better workflows, and focused patient care.
U.S. healthcare AI must follow many rules such as HIPAA for privacy, FDA rules for medical software, and new rules for AI clarity and responsibility.
Ethics focus on making sure AI does not replace important human clinical judgment but helps healthcare workers. Doctors still check AI triage decisions to keep safety and legal responsibility.
Practices must train staff, explain AI use to patients, and watch AI for mistakes or bias.
Medical practice leaders, owners, and IT managers in the U.S. may find AI clinical assistants useful for cutting costs and improving operations in post-surgical triage. AI can lower admin costs, use staff time better, boost patient involvement, and raise clinical safety. Good planning, rule-following, and a balance between human and AI work are important to get the best results and keep patient care safe and high quality.
Dora R1 is designed to conduct autonomous telemedicine follow-up assessments for cataract surgery patients, identifying and prioritizing those who need further clinical input, thereby expanding clinical capacity and improving patient triage post-surgery.
The accuracy was assessed by comparing Dora R1’s decisions on clinical symptoms and need for further review against those of supervising ophthalmologists in a sample of 202 patients following cataract surgery.
Dora R1 demonstrated an overall sensitivity of 94% and specificity of 86%, showing strong alignment with clinical decisions made by ophthalmologists.
Dora R1 showed moderate to strong agreement with clinicians, with kappa coefficients ranging from 0.758 to 0.970 across assessed clinical parameters, indicating high reliability in clinical decision-making.
Safety was affirmed as no patients incorrectly discharged by Dora R1 required additional follow-up after a callback. Unexpected management changes were minimal and coincided with clinician recommendations, indicating safe clinical use.
Feasibility was shown with 96.5% of calls completed autonomously by Dora R1, while usability and acceptability were generally positive, although some patients expressed concerns about the absence of human interaction in complex cases.
Patients generally accepted routine AI follow-ups but worried about the absence of a human component in managing complications, indicating sensitivity to the emotional and clinical nuances of AI communication.
Dora R1 reduced staff costs by approximately £35.18 per patient, highlighting important economic advantages in resource allocation for routine post-surgical follow-ups.
The study recommends further real-world implementation studies involving larger and more diverse patient populations across multiple Trusts to validate safety, effectiveness, and generalizability.
Dora R1 evaluated the clinical significance of five key symptoms commonly monitored post-cataract surgery to decide if patients required further clinical review or could be safely discharged.